Last reviewed · How we verify
Sufentanil and PONV prophylaxis
At a glance
| Generic name | Sufentanil and PONV prophylaxis |
|---|---|
| Also known as | For postoperative pain and PONV treatment in the PACU |
| Sponsor | Zealand University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty (NA)
- Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy (NA)
- Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery (PHASE3)
- The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. (PHASE4)
- Intravenous Dexamethasone Effectiveness in Post Caesarean Section Analgesia (NA)
- Penehyclidine for Prevention of Nausea and Vomiting After Bimaxillary Surgery (NA)
- Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis (NA)
- The Safety and Efficacy of Enhanced Recovery After Surgery on Clinical and Immune Outcomes for Gynecological Oncology (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sufentanil and PONV prophylaxis CI brief — competitive landscape report
- Sufentanil and PONV prophylaxis updates RSS · CI watch RSS
- Zealand University Hospital portfolio CI